JPRN-UMIN000009339已完成2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-B12: A Multi-Center Phase II/III Study in Children with Newly Diagnosed B-cell Precursor Acute Lymphoblastic Leukemia - A Multi-Center Phase II/III Study in Children with B-cell Precursor ALL: JPLSG ALL-B12
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)0 个研究点目标入组 1,940 人开始时间: 2012年11月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,940
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 19years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) mature B-ALL 2) Ph positive ALL 3) True Mixed Lineage Leukemia 4) CNS hemorrage more than grade 3 of CACAE v4.0 5) uncontrolled infection, including active tuberculosis and positive of HIV antibody. 6) pregnancy or high possibility of pregnancy and giving suck wiman. 7) history of congenital or acquired immunodeficiency. 8) QTfc, corrected by Friderics formula as QTfc = QT/RR*1/3, is more than 0.45 seconds. 9) any inappropriate status judged by physician.
研究者
相似试验
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid LeukemiaAcute myeloid Leukemia Myelodysplastic syndromeJPRN-UMIN000000989Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)73
已完成
不适用
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) CML-08: A Multi-Center Observational Study for Children with Chronic Phase of Chronic Myeloid LeukemiaChronic Phase of Chronic Myeloid Leukemia (CML) in childrenJPRN-UMIN000002581Japanese Pediatric Leukemia/Lymphoma Study Group22
招募中
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-T11 and Japan Adult Leukemia Study Group (JALSG) T-ALL-211-U ALL-T11: A Multi-Center Phase II Study in Children and Adolescence with Newly Diagnosed T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LeukemiaJPRN-UMIN000006851Japanese Pediatric Leukemia/Lymphoma Study Group147
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-R11: Multi-center Phase II Study of the efficacy and the safety in the induction chemotherapy containing fludarabine for children with the first bone marrow relapse and induction failure of acute myeloid leukemia.acute myeloid leukemiaJPRN-UMIN000007390Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)50
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-P05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL)Acute promyelocytic leukemiaJPRN-UMIN000000645Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)44